Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion type Assertion NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_head.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion description "[To evaluate the expression of bcl-2 in transitional cell carcinoma (TCC) of the bladder; to compare bcl-2 expression with clinicopathological findings, p53 immunoreactivity, proliferating cell nuclear antigen (PCNA) expression, 2c deviation index (2cDI), 5c exceeding rate (5cER), and the mean nuclear area (MNA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_provenance.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion evidence source_evidence_literature NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_provenance.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion SIO_000772 8707954 NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_provenance.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion wasDerivedFrom befree-2016 NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_provenance.
- NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_assertion wasGeneratedBy ECO_0000203 NP1353853.RAcjbsnz5iL458Sf0WL_uX0wfF8m0BH6jspEuFrENEEZI130_provenance.